magnolin has been researched along with lignin in 5 studies
Studies (magnolin) | Trials (magnolin) | Recent Studies (post-2010) (magnolin) | Studies (lignin) | Trials (lignin) | Recent Studies (post-2010) (lignin) |
---|---|---|---|---|---|
27 | 0 | 19 | 13,390 | 26 | 9,534 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, G; Ma, Y | 1 |
Bataille, CJ; Brown, RC; Bruton, G; Hinks, JD; Swain, NA | 1 |
Huang, Y; Liu, J; Ni, M; Sun, S | 1 |
Jeon, R; Kim, DH; Kim, HD; Kim, JS; Kim, JY; Lee, da Y; Lee, HJ; Lim, HJ; Ryu, JH | 1 |
Chung, WY; Jun, AY; Kim, HJ; Lee, DH; Park, KK; Son, KH; Woo, MH | 1 |
5 other study(ies) available for magnolin and lignin
Article | Year |
---|---|
[Biologically active lignins from Magnolia biondii Pamp].
Topics: Drugs, Chinese Herbal; Lignans; Lignin; Molecular Conformation | 1995 |
C-H insertion approach to the synthesis of endo,exo-furofuranones: synthesis of (+/-)-asarinin, (+/-)-epimagnolin A, and (+/-)-fargesin.
Topics: Anti-Allergic Agents; Anticholesteremic Agents; Antihypertensive Agents; Antineoplastic Agents; Antioxidants; Dioxoles; Drugs, Chinese Herbal; Furans; Lignans; Lignin; Platelet Aggregation Inhibitors | 2001 |
[Study on percutaneous absorption of Xuetie Dingchuan Plaster].
Topics: Administration, Cutaneous; Animals; Azepines; Chromatography, High Pressure Liquid; Dimethyl Sulfoxide; Drugs, Chinese Herbal; Ethanol; Female; In Vitro Techniques; Lignans; Lignin; Liposomes; Male; Mice; Skin Absorption | 2005 |
In vitro anti-inflammatory activity of lignans isolated from Magnolia fargesii.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Humans; I-kappa B Proteins; Lignans; Lignin; Magnetic Resonance Spectroscopy; Magnolia; Neurons; NF-KappaB Inhibitor alpha; Nitric Oxide; Plant Extracts; Transcription Factor RelA | 2009 |
Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts.
Topics: Animals; Benzodioxoles; Bone Resorption; Breast Neoplasms; Cell Line, Tumor; Female; Furans; Gene Expression Regulation, Neoplastic; Humans; Lignans; Lignin; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Osteoblasts; Osteoclasts; Osteoprotegerin; Parathyroid Hormone-Related Protein; RANK Ligand; RNA, Messenger | 2014 |